A drug targeting only p110α can block phosphoinositide 3-kinase signalling and tumour growth in certain cell types
出版年份 2011 全文链接
标题
A drug targeting only p110α can block phosphoinositide 3-kinase signalling and tumour growth in certain cell types
作者
关键词
-
出版物
BIOCHEMICAL JOURNAL
Volume 438, Issue 1, Pages 53-62
出版商
Portland Press Ltd.
发表日期
2011-07-04
DOI
10.1042/bj20110502
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- PI3Kα Inhibitors That Inhibit Metastasis
- (2015) Oncotarget
- Cooperation between Pik3ca and p53 Mutations in Mouse Mammary Tumor Formation
- (2011) J. R. Adams et al. CANCER RESEARCH
- Cell-to-Cell Variability in PI3K Protein Level Regulates PI3K-AKT Pathway Activity in Cell Populations
- (2011) Tina L. Yuan et al. CURRENT BIOLOGY
- Isoform-Specific Phosphoinositide 3-Kinase Inhibitors Exert Distinct Effects in Solid Tumors
- (2010) K. A. Edgar et al. CANCER RESEARCH
- Drugging the PI3 Kinome: From Chemical Tools to Drugs in the Clinic
- (2010) P. Workman et al. CANCER RESEARCH
- Hot-spot mutations in p110α of phosphatidylinositol 3-kinase (PI3K): Differential interactions with the regulatory subunit p85 and with RAS
- (2010) Li Zhao et al. CELL CYCLE
- Docking Studies on Isoform-Specific Inhibition of Phosphoinositide-3-Kinases
- (2010) Dima A. Sabbah et al. Journal of Chemical Information and Modeling
- PTEN restoration and PIK3CB knockdown synergistically suppress glioblastoma growth in vitro and in xenografts
- (2010) Hongbo Chen et al. JOURNAL OF NEURO-ONCOLOGY
- The emerging mechanisms of isoform-specific PI3K signalling
- (2010) Bart Vanhaesebroeck et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Cancer-derived mutations in the regulatory subunit p85 of phosphoinositide 3-kinase function through the catalytic subunit p110
- (2010) M. Sun et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Activity of any class IA PI3K isoform can sustain cell proliferation and survival
- (2010) L. C. Foukas et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MolProbity: all-atom structure validation for macromolecular crystallography
- (2009) Vincent B. Chen et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- AKT-Independent Signaling Downstream of Oncogenic PIK3CA Mutations in Human Cancer
- (2009) Krishna M. Vasudevan et al. CANCER CELL
- PIK3CA and PIK3CB Inhibition Produce Synthetic Lethality when Combined with Estrogen Deprivation in Estrogen Receptor-Positive Breast Cancer
- (2009) R. J. Crowder et al. CANCER RESEARCH
- Differential Enhancement of Breast Cancer Cell Motility and Metastasis by Helical and Kinase Domain Mutations of Class IA Phosphoinositide 3-Kinase
- (2009) H. Pang et al. CANCER RESEARCH
- Targeting the phosphoinositide 3-kinase pathway in cancer
- (2009) Pixu Liu et al. NATURE REVIEWS DRUG DISCOVERY
- A frequent kinase domain mutation that changes the interaction between PI3K and the membrane
- (2009) D. Mandelker et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PTEN and the PI3-Kinase Pathway in Cancer
- (2008) Nader Chalhoub et al. Annual Review of Pathology-Mechanisms of Disease
- A chemical screen in diverse breast cancer cell lines reveals genetic enhancers and suppressors of sensitivity to PI3K isoform-selective inhibition
- (2008) Neil E. Torbett et al. BIOCHEMICAL JOURNAL
- Dissecting isoform selectivity of PI3K inhibitors: the role of non-conserved residues in the catalytic pocket
- (2008) Mark Frazzetto et al. BIOCHEMICAL JOURNAL
- The regulation and function of Class III PI3Ks: novel roles for Vps34
- (2008) Jonathan M. Backer BIOCHEMICAL JOURNAL
- Effects of oncogenic p110α subunit mutations on the lipid kinase activity of phosphoinositide 3-kinase
- (2008) Jeffrey D. Carson et al. BIOCHEMICAL JOURNAL
- Design of Drug-Resistant Alleles of Type-III Phosphatidylinositol 4-Kinases Using Mutagenesis and Molecular Modeling†
- (2008) Andras Balla et al. BIOCHEMISTRY
- Targeting the PI3K p110 Isoform Inhibits Medulloblastoma Proliferation, Chemoresistance, and Migration
- (2008) A. S. Guerreiro et al. CLINICAL CANCER RESEARCH
- Distinct roles of class IA PI3K isoforms in primary and immortalised macrophages
- (2008) E. A. Papakonstanti et al. JOURNAL OF CELL SCIENCE
- Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity
- (2008) S.-M. Maira et al. MOLECULAR CANCER THERAPEUTICS
- Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers
- (2008) Jeffrey A Engelman et al. NATURE MEDICINE
- PTEN-deficient cancers depend on PIK3CB
- (2008) S. Wee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Helical domain and kinase domain mutations in p110 of phosphatidylinositol 3-kinase induce gain of function by different mechanisms
- (2008) L. Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phosphoinositide 3-Kinase p110 Activity: Key Role in Metabolism and Mammary Gland Cancer but Not Development
- (2008) E. Ciraolo et al. Science Signaling
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started